365 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
) a decrease of $0.1 million in personnel costs due to headcount reductions; partially offset by (iv) the reversal of $0.5 million in incentive bonus
8-K
EX-2.1
bfm3g6k0gd rmm01h
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
jbruj4 mmu5
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
0vzm37kpqo5dbak6
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
x38z397r0t3ob1g
9 Nov 23
Prospectus supplement for primary offering
4:11pm
S-8
35dwi47o26e4nm3i2mp
30 Aug 23
Registration of securities for employees
4:31pm
S-8
EX-5.1
arhepx6e7dotgt7j5uj
30 Aug 23
Registration of securities for employees
4:31pm
S-8
EX-23.3
9yqb 3qdactd2hi8x
30 Aug 23
Registration of securities for employees
4:31pm
S-8
ee0ufbubthjwtx7ygpv2
30 Aug 23
Registration of securities for employees
4:31pm
8-K
894ba0gvi8rcwgu 3cc
28 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
uv6g0hfait8c efse5v
16 Aug 23
Departure of Directors or Certain Officers
5:19pm
8-K
cuqbtyb8xy2vp k06kbl
16 Aug 23
Departure of Directors or Certain Officers
5:19pm
8-K
EX-99.1
y1uddco5i2x55g7
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm